載入中
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
收盤時
US$8.39
−US$0.575 · -6.41%
盤後
US$8.39
US$0.00 · 0.00%
10月13日 下午4:37 ET
盤中時間採用ET。市場資料可能有所延遲。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日內區間
目前US$8.39
52週區間
目前US$8.39
盤中時間採用ET。市場資料可能有所延遲。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日內區間
目前US$8.39
52週區間
目前US$8.39
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 7736.3萬 USD | 7986.6萬 USD | 8105.6萬 USD | 7133.1萬 USD | 4895.6萬 USD |
| 銷貨成本 | 1069.7萬 USD | 1158.1萬 USD | 1188.1萬 USD | 1236.1萬 USD | 861萬 USD |
| 毛利 | 6666.6萬 USD | 6828.5萬 USD | 6917.5萬 USD | 5897萬 USD | 4034.6萬 USD |
| 研究與開發 | 1460.6萬 USD | 1799.1萬 USD | 1755.6萬 USD | 2285.9萬 USD | 1563.4萬 USD |
| 銷售、一般及管理費用 | 8915.9萬 USD | 1.01億 USD | 1.09億 USD | 1.2億 USD | 7619萬 USD |
| 營業費用 | 1.04億 USD | 1.19億 USD | 1.26億 USD | 1.43億 USD | 9182.4萬 USD |
| 利息收入 | 397.3萬 USD | — | — | — | — |
| 利息支出 | 514.2萬 USD | 466.2萬 USD | 540.8萬 USD | 446.6萬 USD | 436.6萬 USD |
| 折舊和攤銷 | 48.7萬 USD | 71.2萬 USD | 61.4萬 USD | 71萬 USD | 63.2萬 USD |
| 營業利益 | −3709.9萬 USD | −5053.2萬 USD | −5727.4萬 USD | −8395.4萬 USD | −5147.8萬 USD |
| 淨利 | −3842.6萬 USD | −5150.7萬 USD | −5554.7萬 USD | −8624.2萬 USD | −6296萬 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$7.00
下跌空間 16.57%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI971.04萬0.00%2.3兆 USD0.03%US$381.32-0.07%
iShares Russell 2000 ETFIWM918.8萬0.01%787.4億 USD0.19%US$276.71-0.43%
Vanguard Extended Market ETFVXF347.03萬0.00%954億 USD0.05%US$232.54-0.42%
iShares Russell 2000 Growth ETFIWO319.05萬0.02%139.17億 USD0.24%US$351.1-0.74%
iShares U.S. Small-Cap Equity Factor ETFSMLF198.34萬0.05%41.52億 USD0.15%US$84.90-0.11%
Vanguard Russell 2000 ETFVTWO191.81萬0.01%180億 USD0.06%US$111.77-0.45%
Schwab U.S. Small-Cap ETFSCHA185.53萬0.01%217.13億 USD0.03%US$32.56-0.31%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS172.03萬0.44%3.99億 USD0.60%US$104.83-1.16%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOiShares U.S. Small-Cap Equity Factor ETFSMLFVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAInvesco Dorsey Wright SmallCap Momentum ETFDWASAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
